Paper40959490
Ultrasound-targeted microbubble destruction: a prospective strategy for treating cardiovascular disease.
Yang S and 3 others. Front Cardiovasc Med, 2025. Cited by 3 papers, by iCite.
Cite this record
ConductScience Library. Ultrasound-targeted microbubble destruction: a prospective strategy for treating cardiovascular disease. Papers, record 40959490. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40959490
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Ultrasound-targeted microbubble destruction: a prospective strategy for treating cardiovascular disease.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References123
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 26616760 | Increased local delivery of antagomir therapeutics to the rodent myocardium using ultrasound and microbubbles. | J Control Release | 2016 | https://conductscience.org/library/papers/26616760 | PubMed |
| 2 | 35357625 | Ultrasound-targeted microbubble destruction (UTMD)-mediated miR-150-5p attenuates oxygen and glucose deprivation-induced cardiomyocyte injury by inhibiting TTC5 expression. | Mol Biol Rep | 2022 | https://conductscience.org/library/papers/35357625 | PubMed |
| 3 | 38197549 | Sonogenetics for Monitoring and Modulating Biomolecular Function by Ultrasound. | Angew Chem Int Ed Engl | 2024 | https://conductscience.org/library/papers/38197549 | PubMed |
| 4 | 37994595 | USP28 Serves as a Key Suppressor of Mitochondrial Morphofunctional Defects and Cardiac Dysfunction in the Diabetic Heart. | Circulation | 2024 | https://conductscience.org/library/papers/37994595 | PubMed |
| 5 | 35246339 | Pre-transplantation of Bone Marrow Mesenchymal Stem Cells Amplifies the Therapeutic Effect of Ultrasound-Targeted Microbubble Destruction-Mediated Localized Combined Gene Therapy in Post-Myocardial Infarction Heart Failure Rats. | Ultrasound Med Biol | 2022 | https://conductscience.org/library/papers/35246339 | PubMed |
| 6 | 30150423 | Ultrasound Microbubble Delivery Targeting Intraplaque Neovascularization Inhibits Atherosclerotic Plaque in an APOE-deficient Mouse Model. | In Vivo | 2018 | https://conductscience.org/library/papers/30150423 | PubMed |
| 7 | 27792639 | Downregulation of Renal G Protein-Coupled Receptor Kinase Type 4 Expression via Ultrasound-Targeted Microbubble Destruction Lowers Blood Pressure in Spontaneously Hypertensive Rats. | J Am Heart Assoc | 2016 | https://conductscience.org/library/papers/27792639 | PubMed |
| 8 | 32979007 | Hydrogen sulfide-loaded microbubbles combined with ultrasound mediate thrombolysis and simultaneously mitigate ischemia-reperfusion injury in a rat hindlimb model. | J Thromb Haemost | 2021 | https://conductscience.org/library/papers/32979007 | PubMed |
| 9 | 31096311 | Ultrasound Microbubbles for Diagnosis and Treatment of Cardiovascular Diseases. | Semin Thromb Hemost | 2020 | https://conductscience.org/library/papers/31096311 | PubMed |
| 10 | 31474384 | Effect of Ultrasound on the Vasculature and Extravasation of Nanoscale Particles Imaged in Real Time. | Ultrasound Med Biol | 2019 | https://conductscience.org/library/papers/31474384 | PubMed |
| 11 | 9751673 | Delivery of colloidal particles and red blood cells to tissue through microvessel ruptures created by targeted microbubble destruction with ultrasound. | Circulation | 1998 | https://conductscience.org/library/papers/9751673 | PubMed |
| 12 | 39241549 | MSCs biomimetic ultrasonic phase change nanoparticles promotes cardiac functional recovery after acute myocardial infarction. | Biomaterials | 2025 | https://conductscience.org/library/papers/39241549 | PubMed |
| 13 | 38151837 | Microbubbles: Revolutionizing Biomedical Applications with Tailored Therapeutic Precision. | Curr Pharm Des | 2023 | https://conductscience.org/library/papers/38151837 | PubMed |
| 14 | 34767350 | Ultrasound-Responsive Systems as Components for Smart Materials. | Chem Rev | 2022 | https://conductscience.org/library/papers/34767350 | PubMed |
| 15 | 37150786 | Cell-cycle dependent nuclear gene delivery enhances the effects of E-cadherin against tumor invasion and metastasis. | Signal Transduct Target Ther | 2023 | https://conductscience.org/library/papers/37150786 | PubMed |
| 16 | 30178636 | Use of cationic microbubbles targeted to P-selectin to improve ultrasound-mediated gene transfection of hVEGF165 to the ischemic myocardium. | J Zhejiang Univ Sci B | 2018 | https://conductscience.org/library/papers/30178636 | PubMed |
| 17 | 32548962 | Antagomir-155 Attenuates Acute Cardiac Rejection Using Ultrasound Targeted Microbubbles Destruction. | Adv Healthc Mater | 2020 | https://conductscience.org/library/papers/32548962 | PubMed |
| 18 | 35181472 | Myocardial ischemia-reperfusion injury and the influence of inflammation. | Trends Cardiovasc Med | 2023 | https://conductscience.org/library/papers/35181472 | PubMed |
| 19 | 35350774 | Platelet Membrane Biomimetic Nanoparticles Combined With UTMD to Improve the Stability of Atherosclerotic Plaques. | Front Chem | 2022 | https://conductscience.org/library/papers/35350774 | PubMed |
| 20 | 36656656 | Enhanced Local Delivery of microRNA-145a-5P into Mouse Aorta via Ultrasound-Targeted Microbubble Destruction Inhibits Atherosclerotic Plaque Formation. | Mol Pharm | 2023 | https://conductscience.org/library/papers/36656656 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42797709 | Environmental Contaminants and Osteoporosis-Related Outcomes: A Systematic Review and Meta-Analysis. | Toxics | 2026 | https://conductscience.org/library/papers/42797709 | PubMed |
| 42216426 | Ultrasound-Mediated Thrombolysis: From Mechanistic Insights to Advanced Nanoplatforms and Clinical Translation. | Adv Healthc Mater | 2026 | https://conductscience.org/library/papers/42216426 | PubMed |
| 41965449 | E-selectin-targeted microbubbles combined with ultrasound improves renoprotective effects of methylprednisolone on cisplatin-induced acute kidney injury in rats. | Sci Rep | 2026 | https://conductscience.org/library/papers/41965449 | PubMed |
| 41280653 | Recent progress of nanomaterials for diagnosis and treatment of rejection in heart transplantation. | Front Bioeng Biotechnol | 2025 | https://conductscience.org/library/papers/41280653 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40959490
GET https://conductscience.org/api/papers/v1/40959490/references?page=2